Nasdaq Confirms Polar Power's Compliance with Listing Requirements
Nasdaq's Listing Qualifications Department has confirmed that Polar Power, Inc. meets the minimum stockholders' equity requirement for continued listing.
Stocks · News reference
Nasdaq Notifies Charming Medical Limited of Anticipated Delisting
Nasdaq has notified Charming Medical Limited that its securities are scheduled for delisting from the Nasdaq Stock Market on November 9, 2026.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Nasdaq Reports October 2026 Monthly Volume Statistics
Nasdaq, Inc. has published its monthly trading volume statistics for October 2026 on its investor relations website.
CME vs. SoFi Technologies: Which Financial Stock Is a Better Buy for 2027?
CME Group and SoFi Technologies represent contrasting investment strategies in the financial sector. CME dominates derivatives trading with a 62% net margin, strong cash flow, and dividend payments, while SoFi pursues aggressive growth with 28.8% revenue expansion but negative free cash flow. The author recommends CME for 2027 due to its superior profitability and shareholder returns, though both stocks have underperformed the S&P 500 over five years.
Nasdaq Halts Trading in TJGC Group Limited
Nasdaq, Inc. announced a trading halt in TJGC Group Limited pending the company's satisfaction of a request for additional information.
Georgia Banking Company Approved for Direct Listing on Nasdaq
Georgia Banking Company, Inc. has received approval for a direct listing of its common stock on the Nasdaq Capital Market, with trading expected to commence on October 29, 2026.
CME vs. Mastercard: Which Financial Stock Is a Better Buy in 2026?
CME Group and Mastercard are compared as investment options for 2026. CME dominates derivatives trading with a 62% net margin, lower valuation (P/E 25.3x), and minimal debt (0.1x debt-to-equity), but faces volatile growth averaging 9.5%. Mastercard powers global payments with consistent 14.3% revenue growth, strong free cash flow of $16.4B, but trades at a higher valuation (P/E 33.8x) with 2.5x debt-to-equity. The article suggests CME may appeal to value-focused investors, while Mastercard attracts growth-oriented ones.